Products

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.

See all 1 product →

About Cercare Medical

Cercare Medical is an AI-powered healthcare company specializing in advanced perfusion imaging solutions for neurological diseases. Their software, the Cercare Medical Neurosuite, processes CT, CBCT, and MRI data to provide detailed insights into brain health. This technology goes beyond traditional perfusion imaging by integrating proprietary biomarkers that measure not only blood flow but also oxygenation, offering a more comprehensive assessment of brain tissue pathologies. The software is designed to be fully automated and vendor-neutral, aiming to enhance diagnostic precision, accelerate workflow routines with zero-click post-processing, and improve clinical decision-making.

For physicians, Cercare Medical’s solutions are particularly valuable in critical care settings for conditions such as stroke, oncology, Alzheimer’s, dementia, and COVID-19. The Neurosuite includes products like Cercare CT Stroke, Cercare MR Stroke, and Cercare MR Neuro Advanced, with features such as AI-powered brain masking and editable tumor segmentations. The company’s technology is built on an innovative Vascular Model, which provides unique imaging maps reflecting oxygen availability, cerebral metabolic rate of oxygen (CMRO2), and vascular heterogeneity. These advanced biomarkers and automated pipelines aim to deliver more reliable perfusion outputs and earlier detection of conditions like tumor recurrence, ultimately supporting better treatment and patient outcomes.

Cercare Medical’s software has received CE clearance for all products, with FDA clearance for MR and pending clearance for CT. They have also secured FDA 510(k) clearance for their Oncology Virtual Expert, an AI-powered brain tumor segmentation module. The company collaborates with industry leaders such as Siemens, SECTRA, Aidoc, TeraRecon, Deepc, and Viz.ai, and its technology is adopted by hospitals and clinics in over 30 countries.

Focus Areas

AI-powered perfusion imaging stroke diagnostics neuro-oncology neurodegenerative diseases Alzheimer's disease dementia COVID-19 medical imaging software brain tumor segmentation healthcare analytics computer vision

Business Intelligence

Key InvestorsWest Hill Capital, Bagger-Sørensen Equity, Herfo, European Innovation Council, European Union, Smedvig, Canica
PartnershipsSiemens Healthineers, SECTRA, Aidoc, TeraRecon, Deepc, Viz.ai, mBits, European Society of Neuroradiology (ESNR), Microsoft, Blackford
Acquisitionsunknown
TechnologyAI-powered perfusion imaging solutions, Vascular Model, proprietary biomarkers for blood flow and oxygenation, fully automated, vendor-neutral software for CT, CBCT, and MRI post-processing, on-premise architecture
FDA Clearances3+ (Cercare Perfusion (MRI), Cone-Beam CT Perfusion, Oncology Virtual Expert) cleared products (estimated)

What Physicians Need to Know

Specialization
Cercare Medical specializes in AI-powered perfusion imaging solutions for CT, CBCT, and MRI post-processing, focusing on neurological conditions such as stroke, neuro-oncology, neurodegenerative diseases (Alzheimer's, dementia), and COVID-19.
Key Differentiators
Their core differentiator is the use of proprietary biomarkers and the innovative Vascular Model, which not only measure blood flow but also oxygenation, providing comprehensive insights into patient health. This allows for high-resolution maps of oxygen extraction capacity and metabolism, traditionally assessed with PET, now achievable with MR or CT. They also offer automated detection and segmentation of hypoperfusion and core regions in acute ischemic stroke.
Technology Stack
Cercare Medical's technology is built on a patented algorithm called the Vascular Model and leverages AI for automated, vendor-neutral analysis of brain imaging data. Their software, the Cercare Medical Neurosuite, provides fully automated solutions for CT, CBCT, and MRI, offering standard perfusion maps (MTT, CBV, CBF, Tmax) and advanced perfusion biomarkers (CMRO2, CTH, OEF, COV, and Leakage). They also feature advanced add-ons for ASPECTS, LVO, and ICH in their CT Stroke Advanced product.
Clinical Applications
Their solutions are tailored for stroke care (Cercare CT Stroke, Cercare CT Stroke Advanced, Cercare MR Stroke, Cercare Cone-Beam CT Perfusion, Cercare MR Stroke Advanced) and neuro-oncology and neurodegenerative diseases (Cercare MR Neuro Advanced). The technology supports efficient stroke workflows through automated processing and provides quantitative biomarkers for clinical assessment and decision-making.
Regulatory Clearances
All products have CE clearance, with FDA clearance for MR and pending clearance for CT.
Physician Tip

For physicians, Cercare Medical's solutions offer increased confidence, superior robustness, and earlier detection in conditions like stroke and brain tumors by providing deeper insights beyond traditional perfusion maps. The software delivers actionable insights with the potential to significantly impact patient outcomes by offering high-quality, robust parametric maps using data on tissue oxygenation. The fully automated and vendor-neutral nature of the software, combined with zero-click post-processing, accelerates workflow routines and facilitates faster decision-making. Furthermore, the ability to assess oxygenation and metabolism from standard MR or CT data, traditionally requiring PET, can revolutionize patient management. The integration of Cone-Beam CT Perfusion directly into the angio suite, as seen in their partnership with Siemens Healthineers, allows for real-time tissue viability assessment during intervention, potentially streamlining workflows and shortening time to treatment for stroke patients.

Cercare Medical's technology is widely adopted through strategic partnerships with industry leaders such as Siemens, SECTRA, Aidoc, TeraRecon, Deepc, and Viz.ai. Their solutions are designed for seamless integration with PACS and other systems, ensuring secure and accessible image sharing across departments. The Cercare Medical Neurosuite is a vendor-neutral software, compatible with various CT, CBCT, and MRI systems.

Products by Cercare Medical

1 product in the directory

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.

What the Web Says

Cercare Medical is a Danish company founded in 2013 that specializes in AI-powered perfusion imaging solutions for neurological diseases, including stroke, oncology, Alzheimer's, and dementia. Their software, Cercare Medical Neurosuite, offers advanced imaging analysis for CT, CBCT, and MRI post-processing, utilizing proprietary biomarkers that measure both blood flow and oxygenation. The company operates globally with direct sales teams in several regions and strategic partnerships with industry leaders like Siemens. Recently, Cercare Medical received FDA clearance for its Oncology Virtual Expert module, an AI-powered brain tumor segmentation tool designed for existing clinical radiology workflows.

Overall: Positive

Strengths

  • Ease of use, reliability, and speed of their perfusion software.
  • Increased confidence, superior robustness, and earlier tumor detection with their Neurosuite.
  • Advanced biomarkers and maps offer deeper diagnostic value beyond traditional perfusion measurements.
  • Semi-automated tumor segmentation from standard MRI data without manual delineation.
  • On-premise architecture designed to meet HIPAA compliance and data governance requirements.
  • Seamless integration into existing PACS and radiology workflows.

Limitations

  • No specific cons were found in the provided search results from G2, Glassdoor, Capterra, healthcare IT reviewers, or Reddit.

Based on reviews from: Siemens Healthineers Digital Marketplace, AuntMinnie, MPO (Medical Product Outsourcing)

Last updated: 2026-09-30

Videos

News, demos, and interviews about Cercare Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cercare Medical →

View all on YouTube

Press & Coverage

Cercare Medical
Cercare Medical Secures u20ac7.4 Million in New Funding Round to Accelerate Growth in Key Markets
Cercare Medical has secured u20ac7.4 million in a funding round led by West Hill Capital to expand operations in the US, UK, and selected European countries, focusing on its advanced perfusion software for brain tissue pathologies.
2025-03
Cercare Medical
Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation
Cercare Medical announced FDA 510(k) clearance for its Oncology Virtual Expert, an AI-powered brain tumor segmentation module for semi-automated analysis within clinical radiology workflows, marking a strategic expansion into the North American market.
2026-06
Cercare Medical
Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion
Cercare Medical received FDA 510(k) clearance for its Cone-Beam CT (CBCT) Perfusion solution, enabling real-time qualitative perfusion assessment directly from CBCT data during neurointerventional procedures for acute stroke patients.
2026-05
Siemens Healthineers
Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment
Siemens Healthineers and Cercare Medical have partnered globally to accelerate the adoption of CBCT perfusion in acute stroke care, combining Cercare's software with Siemens' Syngo DynaCT technology for comprehensive stroke treatment.
2026-05
Cercare Medical
Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows
Cercare Medical launched CERCARE MEDICAL NEUROSUITE (CMN) Version 18, introducing AI-powered brain masking, improved PACS integration, and enhanced tumor and perfusion workflows based on clinical feedback.
2026-02
Cercare Medical
Cercare Medical Selected for Nationwide Hospital Rollout in Norway
Cercare Medical was selected in the Norwegian National Tender for advanced imaging software, securing installation across every public hospital in Norway for stroke and oncology diagnostics, in collaboration with Deepc.
2025-06
Cercare Medical
Cercare Medical Partners with the European Society of Neuroradiology to Support Perfusion Summit 2027
Cercare Medical announced an educational collaboration with the European Society of Neuroradiology (ESNR) to support the Perfusion Summit 2027, with ESNR endorsing the event and co-hosting a webinar.
2026-09
Cercare Medical
Research Highlight: Cortical Thickness Changes Precede High Levels of Amyloid by at Least 7 Years
This research highlight from Cercare Medical discusses how cortical thickness changes can precede high levels of amyloid by at least seven years, indicating potential for earlier detection of neurodegenerative conditions.
2026-09
No FAQs available yet for this company.

Related Companies

BastionGPT, developed by Bastion Intelligence, offers HIPAA-compliant AI tools specifically designed for physicians and healthcare providers. The platform aims to reduce the administrative burden of documentation, allowing clinicians to focus more on patient care. It provides an AI assistant and an unlimited ambient AI scribe, converting dictations, recordings, and uploaded records into structured medical documentation […]

Videa (formerly VideaHealth) is a healthcare AI company focused on transforming dentistry through artificial intelligence. The company develops AI software that analyzes dental radiographs (X-rays) to assist dentists in detecting various oral conditions, such as cavities, gum disease, periapical lesions, calculus, and periodontal bone loss. Their core product, the “VideaAI” platform, is an FDA-cleared software […]

The Real Estate Physician is a company that empowers physicians to achieve financial independence through real estate investing. Founded by Dr. Cherry Chen and Alex Luu in 2018, the company provides guidance, education, and support to help healthcare professionals invest in commercial real estate opportunities. They aim to help physicians put their money to work, […]

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

SureMediks, a product of Rasimo Systems, LLC, is an AI-powered Clinical Operating System designed for longitudinal care, aiming to transform episodic healthcare into continuous, intelligent, and personalized patient management. The platform integrates patients, healthcare providers, clinical protocols, AI, connected medical devices, and electronic medical records into a unified ecosystem. SureMediks processes continuous real-world patient data […]

SOAP Health offers an AI-powered platform designed to enhance patient intake, risk assessment, and clinical documentation for physicians. The company’s core offering, “The Ideal Medical AI Assistant™,” utilizes conversational and generative AI with an animated digital human interface to collect comprehensive patient data through voice-based interactions. This system aims to save physicians significant time by […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.